|
CARLOS R. HAMILTON, JR., MD, FACE President of the American College of Endocrinology
Professor of Internal medicine University of Texas Houston Medical School Carlos R. Hamilton, Jr., MD, FACE, has practiced clinical endocrinology and internal medicine, and he is the executive vice president of the University of Texas Health Science Center at Houston and a professor of internal medicine at the UT Houston Medical School. After graduating from Baylor College of Medicine, he completed his internship and residency at the Johns Hopkins Hospital, an endocrine fellowship at the Massachusetts General Hospital, and was chief resident in medicine at Hopkins. He was on the full-time faculty at Hopkins before serving two years as an endocrinologist at the Wilford Hall USAF Medical Center in San Antonio. He was in private practice for 26 years and was a clinical professor of medicine at Baylor College of Medicine before assuming his present position. Dr. Hamilton has been active in medical organizations primarily as an advocate for medical practice and patient's rights. He has been a member of the AACE board of directors and served as chair of the AACE legislative and regulatory committee. He has also served as president of the Texas Society of Internal Medicine, the Harris County Medical Society and as chair of the Texas Medical Association Political Action Committee. He has served as a trustee of the American Society of Internal Medicine, as a member of the ACP-ASIM Health and Public Policy Committee and as a member of the AMA Federation Advisory Committee. He served as the 2004–2005 AACE president and as a trustee of the American College of Endocrinology. He is a past president on the AACE board of directors and president-elect of the American College of Endocrinology. He is a member of the practicing physicians advisory council to the US Secretary of Health and Human Services for issues related to the Center of Medicare and Medicaid Services. He also serves on the health, medicine and research committee of the World Anti-Doping Agency, which oversees the international prohibitions of the use of hormones and performance enhancing substances in athletic competition. Assistant Professor of Medicine
State University of New York Buffalo, New York Joseph J. Torre, M.D., F.A.C.P., F.A.C.E., is Clinical Assistant Professor of Medicine for the State University of New York at Buffalo where he has been in the private practice of endocrine consultation with the Buffalo Medical Group, P.C. since 1991. He served as chairman of the task force that developed the AACE Medical Guidelines for the Diagnosis and Management of Hypertension and as section editor of the Hypertension module of the AACE/ACE Self Assessment Program (ASAP) for 2007-2008. A graduate of the Boston University School of Medicine, his endocrinology career stemmed from an interest in the etiology of atherogenesis and research in platelet sensitivity and vascular reactivity associated with hyperlipidemia and diabetes mellitus at St. Luke’s Hospital Medical Center in NYC, NY, and later at the M.I.T. Arteriosclerosis Center in Cambridge, MA. Dr. Torre sees the clinical endocrinologist as the quintessential diagnostician and preventive medicine specialist. He credits AACE with helping to bring endocrinology from an esoteric subspecialty to the forefront of the clinical practice of internal medicine. Professor of Medicine
Baylor College of Medicine
Addison A. Taylor, M.D., Ph.D., F.A.H.A., is a Professor of Medicine, Professor of Pharmacology, and Professor of Molecular Physiology and Biophysics, and is the Chief of the Section of Hypertension and Clinical Pharmacology in the Department of Medicine, Baylor College of Medicine. He has been a principal investigator or co-principal investigator in over 400 clinical trials investigating mechanisms and new therapies for hypertension and hypotension. He has authored or co-authored over 120 scientific publications, and has participated as an invited speaker at many national and international meetings. In addition, Dr. Taylor serves as a consultant to the Cardiovascular and Renal Drug Advisory Committee of the Food and Drug Administration. Dr. Taylor is a Fellow of the American Heart Association and is a member of the Council for High Blood Pressure Research, the Council for Basic Cardiovascular Research, and the Council for Arteriosclerosis, Thrombosis and Vascular Biology of the American Heart Association. Dr. Taylor received his M.D. and Ph.D. degrees from the University of Missouri in Columbia. He also spent six years at the National Heart, Lung and Blood Institute of the National Institutes of Health in Maryland before joining the Baylor faculty in 1977.
|
||